-
Sequoia Capital's Turbulent Year: Partners Exit On Heels Of FTX Collapse, $214M Loss
Thursday, July 20, 2023 - 12:14pm | 628Read More...Venture firm Sequoia Capital has undergone significant changes over the past year, marked by market volatility, a split, and the departure of at least five investors. What Happened: Michael Moritz, a long-standing partner since 1986, is stepping away from the venture firm to concentrate on Sequoia...
-
4 Key WWDC Takeaways From An Apple Bull
Tuesday, June 6, 2017 - 10:19am | 564Read More...While there were no groundbreaking announcements, Apple Inc. (NASDAQ: AAPL)'s WWDC keynote address Monday was filled with more product launches than investors anticipated. After the address, Bernstein Research analyst Toni Sacconaghi rated Apple at Outperform and set a $160 price target. 4 Key...
-
Tesla Is 'Burning Rubber And Burning Cash'
Thursday, March 9, 2017 - 10:32am | 291Read More...Tesla Inc (NASDAQ: TSLA) is continuing to disrupt the traditional automotive market. “While we are bullish about Tesla's long-term potential, we have several near-term concerns,” Bernstein’s Daniel Chen said in a report. Initiating coverage of Tesla with a Market Perform...
-
In The Fight Against Cancer, Roche And AstraZeneca Are Looking At Trillions Of Bacteria That Live In The Body
Monday, March 14, 2016 - 2:37pm | 328Read More...Top scientists at Roche Holding Ltd. (ADR) (OTC: RHHBY) and AstraZeneca plc (ADR) (NYSE: AZN) are studying the possibilities of using bacteria in gut to fight cancer, according to a report on Bloomberg. Drugmakers are showing interest in the human microbiome -- the universe of roughly 100...
